Literature DB >> 3949022

The effects of long-term androgen treatment on the ovary.

H Amirikia, R T Savoy-Moore, A S Sundareson, K S Moghissi.   

Abstract

Ten patients with female gender dysphoria were treated with exogenous androgen (testosterone [T] enanthate USP) and underwent sex reassignment surgery. Histologic changes of the ovaries of this treated group were studied and compared with those of patients with polycystic ovarian syndrome (PCO) and a normal control group. Significant differences among groups were observed for thickness of the tunica albuginea (639.8 +/- 56.5 micron, 529.2 +/- 59.3 micron, and 170.1 +/- 29.8 micron in the exogenous androgens, PCO, and normal groups, respectively), basal membrane thickness (72.8 +/- 2.8 micron, 46.2 +/- 4.2 micron, and 25.2 micron), number of cystic follicles (2.0 +/- 0.4, 5.8 +/- 0.7, and 1.8 +/- 0.8), and T and luteinizing hormone concentrations. Theca cell hyperplasia was present only in the PCO group. It is concluded that exogenous androgen can thicken the tunica albuginea and basal membrane and that these histologic changes are similar to those seen in PCO ovaries under excess endogenous androgen production.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3949022     DOI: 10.1016/s0015-0282(16)49155-7

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  10 in total

Review 1.  Fertility preservation options in transgender people: A review.

Authors:  Natnita Mattawanon; Jessica B Spencer; David A Schirmer; Vin Tangpricha
Journal:  Rev Endocr Metab Disord       Date:  2018-09       Impact factor: 6.514

Review 2.  Impact of Exogenous Testosterone on Reproduction in Transgender Men.

Authors:  Molly B Moravek; Hadrian M Kinnear; Jenny George; Jourdin Batchelor; Ariella Shikanov; Vasantha Padmanabhan; John F Randolph
Journal:  Endocrinology       Date:  2020-03-01       Impact factor: 4.736

Review 3.  Cross-sex hormone therapy for gender dysphoria.

Authors:  B Fabris; S Bernardi; C Trombetta
Journal:  J Endocrinol Invest       Date:  2014-11-18       Impact factor: 4.256

Review 4.  Testosterone therapy for women with poor ovarian response undergoing IVF: a meta-analysis of randomized controlled trials.

Authors:  Marco Noventa; Amerigo Vitagliano; Alessandra Andrisani; Mija Blaganje; Paola Viganò; Enrico Papaelo; Marco Scioscia; Francesco Cavallin; Guido Ambrosini; Mauro Cozzolino
Journal:  J Assist Reprod Genet       Date:  2019-01-05       Impact factor: 3.412

5.  Update on the use of dehydroepiandrosterone supplementation among women with diminished ovarian function.

Authors:  David Barad; Hyama Brill; Norbert Gleicher
Journal:  J Assist Reprod Genet       Date:  2007-12-11       Impact factor: 3.412

6.  A mouse model to investigate the impact of testosterone therapy on reproduction in transgender men.

Authors:  H M Kinnear; E S Constance; A David; E E Marsh; V Padmanabhan; A Shikanov; M B Moravek
Journal:  Hum Reprod       Date:  2019-10-02       Impact factor: 6.918

7.  Ovarian Histopathology in Transmasculine Persons on Testosterone: A Multicenter Case Series.

Authors:  Frances W Grimstad; Kylie G Fowler; Erika P New; Cecile A Ferrando; Robert R Pollard; Graham Chapman; Meredith Gray; Veronica Gomez Lobo
Journal:  J Sex Med       Date:  2020-07-20       Impact factor: 3.802

8.  Long-term treatment with dehydroepiandrosterone may lead to follicular atresia through interaction with anti-Mullerian hormone.

Authors:  Keiko Ikeda; Tsuyoshi Baba; Miyuki Morishita; Hiroyuki Honnma; Toshiaki Endo; Tamotsu Kiya; Tsuyoshi Saito
Journal:  J Ovarian Res       Date:  2014-04-30       Impact factor: 4.234

9.  Effect of the spatial-temporal specific theca cell Cyp17 overexpression on the reproductive phenotype of the novel TC17 mouse.

Authors:  Christian Secchi; Martina Belli; Tracy N H Harrison; Joseph Swift; CheMyong Ko; Antoni J Duleba; Dwayne Stupack; R Jeffrey Chang; Shunichi Shimasaki
Journal:  J Transl Med       Date:  2021-10-15       Impact factor: 5.531

10.  Changes in clinical and biochemical characteristics of polycystic ovary syndrome with advancing age.

Authors:  Sebastião Freitas de Medeiros; Márcia Marly Winck Yamamoto; Matheus Antônio Souto de Medeiros; Bruna Barcelo Barbosa; José Maria Soares; Edmund Chada Baracat
Journal:  Endocr Connect       Date:  2020-02       Impact factor: 3.335

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.